Lessons from a Decade of Integrating Cancer Copy Number Alterations with Gene Expression Profiles

Overview

Journal Brief Bioinform

Publisher Oxford University Press

Specialty Biology

Date 2011 Sep 28

PMID 21949216

Citations 25

Authors

Norman Huang

Parantu K Shah

Cheng Li

Affiliations

Soon will be listed here.

Abstract

Over the last decade, multiple functional genomic datasets studying chromosomal aberrations and their downstream effects on gene expression have accumulated for several cancer types. A vast majority of them are in the form of paired gene expression profiles and somatic copy number alterations (CNA) information on the same patients identified using microarray platforms. In response, many algorithms and software packages are available for integrating these paired data. Surprisingly, there has been no serious attempt to review the currently available methodologies or the novel insights brought using them. In this work, we discuss the quantitative relationships observed between CNA and gene expression in multiple cancer types and biological milestones achieved using the available methodologies. We discuss the conceptual evolution of both, the step-wise and the joint data integration methodologies over the last decade. We conclude by providing suggestions for building efficient data integration methodologies and asking further biological questions.

Citing Articles

Obscurin: A multitasking giant in the fight against cancer.

Guardia T, Eason M, Kontrogianni-Konstantopoulos A Biochim Biophys Acta Rev Cancer. 2021; 1876(1):188567.

PMID: 34015411 PMC: 8349851. DOI: 10.1016/j.bbcan.2021.188567.

A meta-analysis of multiple matched aCGH/expression cancer datasets reveals regulatory relationships and pathway enrichment of potential oncogenes.

Newton R, Wernisch L PLoS One. 2019; 14(7):e0213221.

PMID: 31335867 PMC: 6650054. DOI: 10.1371/journal.pone.0213221.

MVisAGe Identifies Concordant and Discordant Genomic Alterations of Driver Genes in Squamous Tumors.

Walter V, Du Y, Danilova L, Hayward M, Hayes D Cancer Res. 2018; 78(12):3375-3385.

PMID: 29700001 PMC: 6028011. DOI: 10.1158/0008-5472.CAN-17-3464.

Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes.

Tokar T, Pastrello C, Ramnarine V, Zhu C, Craddock K, Pikor L Oncotarget. 2018; 9(10):9137-9155.

PMID: 29507679 PMC: 5823624. DOI: 10.18632/oncotarget.24070.

Driver pattern identification over the gene co-expression of drug response in ovarian cancer by integrating high throughput genomics data.

Lu X, Lu J, Liao B, Li X, Qian X, Li K Sci Rep. 2017; 7(1):16188.

PMID: 29170526 PMC: 5700962. DOI: 10.1038/s41598-017-16286-5.

References

Peng J, Zhu J, Bergamaschi A, Han W, Noh D, Pollack J . Regularized Multivariate Regression for Identifying Master Predictors with Application to Integrative Genomics Study of Breast Cancer. Ann Appl Stat. 2014; 4(1):53-77. PMC: 3905690. DOI: 10.1214/09-AOAS271SUPP. View

Schimke R, Kaufman R, Alt F, Kellems R . Gene amplification and drug resistance in cultured murine cells. Science. 1978; 202(4372):1051-5. DOI: 10.1126/science.715457. View

van de Wiel M, Picard F, van Wieringen W, Ylstra B . Preprocessing and downstream analysis of microarray DNA copy number profiles. Brief Bioinform. 2010; 12(1):10-21. DOI: 10.1093/bib/bbq004. View

Akavia U, Litvin O, Kim J, Sanchez-Garcia F, Kotliar D, Causton H . An integrated approach to uncover drivers of cancer. Cell. 2010; 143(6):1005-17. PMC: 3013278. DOI: 10.1016/j.cell.2010.11.013. View

Kingsley C, Kuo W, Polikoff D, Berchuck A, Gray J, Jain A . Magellan: a web based system for the integrated analysis of heterogeneous biological data and annotations; application to DNA copy number and expression data in ovarian cancer. Cancer Inform. 2009; 2:10-21. PMC: 2675496. View

Gu W, Choi H, Ghosh D . Global associations between copy number and transcript mRNA microarray data: an empirical study. Cancer Inform. 2009; 6:17-23. PMC: 2623285. DOI: 10.4137/cin.s342. View

Woo H, Park E, Lee J, Lee Y, Ishikawa T, Kim Y . Identification of potential driver genes in human liver carcinoma by genomewide screening. Cancer Res. 2009; 69(9):4059-66. PMC: 2750086. DOI: 10.1158/0008-5472.CAN-09-0164. View

Tsukamoto Y, Uchida T, Karnan S, Noguchi T, Nguyen L, Tanigawa M . Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J Pathol. 2008; 216(4):471-82. DOI: 10.1002/path.2424. View

Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E . Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res. 2002; 62(21):6240-5. View

10.

Louhimo R, Hautaniemi S . CNAmet: an R package for integrating copy number, methylation and expression data. Bioinformatics. 2011; 27(6):887-8. DOI: 10.1093/bioinformatics/btr019. View

11.

Gorre M, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao P . Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science. 2001; 293(5531):876-80. DOI: 10.1126/science.1062538. View

12.

Jarvinen A, Autio R, Haapa-Paananen S, Wolf M, Saarela M, Grenman R . Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses. Oncogene. 2006; 25(52):6997-7008. DOI: 10.1038/sj.onc.1209690. View

13.

Merlo L, Pepper J, Reid B, Maley C . Cancer as an evolutionary and ecological process. Nat Rev Cancer. 2006; 6(12):924-35. DOI: 10.1038/nrc2013. View

14.

Peiffer D, Le J, Steemers F, Chang W, Jenniges T, Garcia F . High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res. 2006; 16(9):1136-48. PMC: 1557768. DOI: 10.1101/gr.5402306. View

15.

Taylor B, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver B . Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010; 18(1):11-22. PMC: 3198787. DOI: 10.1016/j.ccr.2010.05.026. View

16.

Li R, Sonik A, Stindl R, Rasnick D, Duesberg P . Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. Proc Natl Acad Sci U S A. 2000; 97(7):3236-41. PMC: 16222. DOI: 10.1073/pnas.97.7.3236. View

17.

Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang S . PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997; 275(5308):1943-7. DOI: 10.1126/science.275.5308.1943. View

18.

Berger J, Hautaniemi S, Mitra S, Astola J . Jointly analyzing gene expression and copy number data in breast cancer using data reduction models. IEEE/ACM Trans Comput Biol Bioinform. 2006; 3(1):2-16. DOI: 10.1109/TCBB.2006.10. View

19.

Nagai M, Yamamoto L, Salaorni S, Pacheco M, Brentani M, Barbosa E . Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours. Genes Chromosomes Cancer. 1994; 11(1):58-62. DOI: 10.1002/gcc.2870110109. View

20.

Chiang D, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B . Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res. 2008; 68(16):6779-88. PMC: 2587454. DOI: 10.1158/0008-5472.CAN-08-0742. View